跳至主要内容
临床试验/CTRI/2025/08/092998
CTRI/2025/08/092998
尚未招募
2 期

A Randomized Open Label Controlled Clinical Study to Evaluate the Efficacy of Mudgadya Ghrit Uttarbasti and Apamarg Kshar Taila Uttarbasti in the Management of Vataja Asrigdar w.s.r Adenomyosis

Institute for Ayurved Studies and Research1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年12月1日最近更新:

概览

阶段
2 期
状态
尚未招募
发起方
Institute for Ayurved Studies and Research
入组人数
40
试验地点
1
主要终点
1 To improve the grading of Menorrhagia

概览

简要总结

PRIMARY PURPOSE IS TREATMENT

ADENOMYOSIS IS A CONDITION WHERE THERE IS A INGROWTH OF ENDOMETRIUM DIRECTLY INTO THE MYOMETRIUM. PREVALENCE OF ADENOMYOSIS  IN CASE OF ENDOMETRIOSIS IS 70 PERCENT AND THE PREVALENCE IS FOUND TO BE 23.5 PERCENT IN PATIENTS WHO HAD COMPLAIN OF MENORRHAGIA 70 PERCENT  FOLLOWED BY DYSMENORRHEA  30 PERCENT.  THE PATIENTS ARE USUALLY PAROUS 90 PERCENT  WITH ABOVE AGE 40. THE PATIENT WITH ADENOMYOSIS  USUALLY PRESENT WITH MENORRHAGIA, DYSMENORRHEA, DYSPAREUNIA , INCREASE THE FREQUENCY OF MICTURITION AND INFERTILITY. IN MODERN MEDICINE,  THE MAIN OBJECTIVE OF MANAGEMENT IS  RELIEF FROM PAIN AND REDUCTION OF EXCESSIVE MENSTRUAL BLEEDING.  MOSTLY USE NSAIDS AND HORMONAL THERAPIES AND LAST OPTION IS HYSTERECTOMY.  HOWEVER  LONG TERM USE OF THESE MEDICATIONS  MAY LEAD TO ADVERSE EFFECTS  ON WOMENS HEALTH. AYURVEDA AS A HOLISTIC SCIENCE AND WAY OF LIVING OFFERS PROMISING ALTERNATIVE  TREATMENT MODALITIES THAT CAN POTENTIALLY  REPLACE OR COMPLEMENT ALLOPATHIC APPROACHES WHILE MINIMIZING HARMFUL SIDE EFFECTS.

IN VIEW OF THIS EFFECT OF MUDGADYA GHRIT UTTARBASTI AND APAMARG KSHAR TAILA UTTARBASTI IN THE MANAGEMENT OF ADENOMYOSIS WSR VATAJA ASRIGDAR. THIS STUDY INVOLVES 40 PATIENTS.  THESE 40 PATIENTS  ARE DIAGNOSED WITH  ADENOMYOSIS  BASED ON CLINICAL EVALUATION AND SUPPORTING INVESTIGATIONS. MUDGADYA GHRITA  AND APAMARG KSHAR TAILA ARE DIVIDED INTO 2 GROUPS . THIS WILL BE ADMINISTERED FOR 3 MONTHS IN FORM OF UTTARBASTI  AFTER CESSATION OF MENSES AIMING TO RESOLVE THE SYMPTOMS OF ADENOMYOSIS SUCH AS MENORRHAGIA,  DYSMENORRHEA  AND OTHER SYMPTOMS  RESOLVE MUSA CRITERIA FOR ADENOMYOSIS . OUTCOME MEASURE WILL INCLUDES BOTH SUBJECTIVE AND OBJECTIVE PARAMETERS. ALTHOUGH, ADENOMYOSIS IS NOT DIRECTLY CORRELATED WITH ANY DISEASE IN AYURVEDA BUT ON THE BASIS OF SYMPTOMS ADENOMYOSIS CAN BE CORRELATED WITH VATAJA ASRIGDAR. THIS STUDY AS TO PROVIDE AN EASY AND POTENTIALLY SAFER ALTERNATIVE TO CONVENTIONAL TREATMENT.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1 Married female Patients of age between 21 to 50years 2 Patients willing to participate in Clinical Trial 3 Patient having Heamoglobin greater than 7gm percent 4 Patients having symptoms of AUB or frothy bleeding or Menorrhagia with one all the following symptoms such as dysmenorrhea dyspareunia and known case of Adenomyosis confirmed by any diagnostic technique 5 Patients are Yogya for Uttarbasti procedure.

排除标准

  • 1 All pregnant women 2 Patients not willing for trial 3 Patient having Systemic Disease like Diabetes FBS greater than 125 mg per dl,Hypertension greater than 140 by 90mm of Hg,Severe Anemia Hb less than 7 gm percent 4 Patients having coagulation disorders, cardiovascular disorders, Cerebrovascular accidents 5 Patients suffering from Malignancy 6 Patient with congenital anamoly of reproductive tract 7 Acute inflammatory disease like Sexual Transmitted Disease like HIV, VDRL,HBsAg, HCV positive females 8 Patient Ayogya for Uttarbasti procedure.

结局指标

主要结局

1 To improve the grading of Menorrhagia

时间窗: Follow up will be done on 30,60,90,120 days

次要结局

  • 1 Improvement in the Heamoglobin level(2 To resolve MUSA Criteria for Adenomyosis)

研究者

发起方
Institute for Ayurved Studies and Research
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Prajkta Gajanan Chaudhari

Institute for Ayurved Studies and Research

研究点 (1)

Loading locations...

相似试验